Eupraxia Pharmaceuticals Inc.
- EPRX
- NASDAQ
- Biotechnology
- Clinical-Stage Biotech
- Drug Delivery (Diffusphere)
$6.62
Today −2.22%Quote Oct 16, 2026, 08:00 PM UTC
−21.00%over the last month
Max drawdown −27.6%From 1-month high −27.3%3 months +6.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$438.4M
Approximate share count
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$17.50
+164.4% from here
Floor
$6.53
1.3% below price
Where the price sits
2 analysts
Analyst range, low to high
$11.00$25.00
- Price $6.62
- Resistance $6.78–$6.85
- Consensus $17.50
The price is just above its floor and right under resistance. Analysts' average target sits about 164% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about EPRXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
49
Founded
2011